Home Featured Alexandria LaunchLabs to Open in Fall 2018

Alexandria LaunchLabs to Open in Fall 2018


Alexandria Real Estate Equities Inc., an urban office REIT uniquely focused on collaborative life science and technology campuses in AAA innovation cluster locations, recently revealed the expansion of Alexandria LaunchLabs—its premier, full-service life science startup platform—into East Cambridge.

Alexandria LaunchLabs will open in the fall of 2018 in One Kendall Square, said to be one of the most sought-after locations for life science companies in the US.

Building upon the success of Alexandria LaunchLabs‘ initial flagship site, which opened at the Alexandria Center® for Life Science – New York City in June 2017, the company will now bring its validated Alexandria LaunchLabs platform to Cambridge to meet the cluster’s critical demand for life science startup space.

Strategically located on the historic Alexandria Center at One Kendall Square campus, Alexandria LaunchLabs will provide member companies with more than 20,000 square feet of cost-effective and collaborative co-working space, including flexible shared or private office/laboratories, shared equipment and services, state-of-the-art conferencing amenities, top-notch mentorship and highly curated programming. It will also feature an on-site management team with a strong background in life science, laboratory operations, entrepreneurship, venture capital and investor relations to provide member companies with best-in-class resources to enhance their growth trajectories.

Qualified member companies will also have the opportunity to access seed capital and mentorship through the Alexandria Seed Capital Platform, a novel funding model that brings together leaders from across the life science community to catalyze seed-stage investment in the most promising life science startups. The Alexandria Seed Capital Platform is led by Alexandria Venture Investments and supported by a preeminent Advisory Board of seasoned biopharma and venture capital executives from Accelerator Life Science Partners, ARCH Venture Partners, Eli Lilly and Company, Pfizer and Roche.

“Cambridge is one of the most innovative and diverse life science and technology ecosystems in the world, and we have spent two decades creating vibrant and collaborative communities on our campuses to drive the discovery and development of treatments and cures for patients,” says Joel S. Marcus, chairman, chief executive officer and founder of Alexandria Real Estate Equities Inc. and Alexandria Venture Investments.

According to Marcus, “Our proven track record of providing first-in-class office and laboratory space to emerging startups and venture-backed companies, as well as our deep expertise in providing funding and accelerating company growth, distinctly positions us to extend the Alexandria LaunchLabs platform into Cambridge.”

According to a company statement, Alexandria is the leading innovator of proprietary space offerings for life science companies at all stages of development. With early roots in the Cambridge market, Alexandria opened its first Science Hotel in 2002 at 790 Memorial Drive in Cambridge, which consists of pre-built office/laboratory suites, with accompanying amenities, designed for maturing, venture-backed companies.

Warning: A non-numeric value encountered in /home/scopii47/public_html/thereitwire.com/wp-content/themes/Newsmag/includes/wp_booster/td_block.php on line 997